Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids.
Egidi
M Francesca
MF
Gaber
A Osama
AO
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D044383:Black People; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000208:ethnology*; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D001741:Black or African American
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D020123:Sirolimus; D016559:Tacrolimus